Prospective study of human immunodeficiency virus 1-related disease among 512 infants born to infected women in New York City

Pediatric Infectious Disease Journal

Volumn 15, Issue 10, 1996, Pages 891-898

  Bamji, Mahrukh ^a   Thea, Donald M ^b,h   Weedon, Jeremy ^b   Krasinski, Keith ^c   Matheson, Pamela B ^b   Thomas, Pauline ^d   Lambert, Genevieve ^e   Abrams, Elaine J ^f   Steketee, Rick ^g   Heagarty, Margaret ^f  

^a METROPOLITAN HOSPITAL CENTER   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^e BRONX LEBANON HOSPITAL CENTER   (United States)

^f HARLEM HOSPITAL CENTER   (United States)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^h Box 44 ^*  (United States)

Author keywords

morbidity; mortality; natural history; Pediatric acquired immunodeficiency syndrome; perinatal transmission; vertical transmission

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CHILD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFANT MORTALITY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; SURVIVAL;

CD4 LYMPHOCYTE COUNT; CHILD, PRESCHOOL; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INCIDENCE; INFANT; LONGITUDINAL STUDIES; NEW YORK CITY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 16044367057     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199610000-00012     Document Type: Article

References (31)

1. Davis SF, Byers RH Jr., Lindegren ML, Caldwell MB, Karon JM, Gwinn M. Prevalence and incidence of vertically acquired HIV infection in the United States. JAMA 1995;27:952-5.
2. New York City Department of Health. AIDS surveillance update: Fourth Quarter 1994. AIDS Surveillance Update 1995.
3. Scott GB, Hutto C, Makuch RW, et al. Survival in children with perinatally acquired human immunodeficiency virus type 1 infection. N Engl J Med 1989;321:1791-6.
4. Krasinski K, Borkowsky W, Holzman RS. Prognosis of human imunodeficiency virus infection in children and adolescents. Pediatr Infect Dis J 1989;8:216-20.
5. Auger I, Thomas P, De Gruttola V, et al. Incubation periods for paediatric AIDS patients. Nature 1988;336:575-7.
6. Blanche S, Tardieu M, Duliege AM, et al. Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Am J Dis Child 1990;144: 1210-5.
7. Byers RH, Caldwell B, Oxtoby MJ. Survival of children with perinatal HIV-infection: evidence for two distinct populations [Abstract WS-C10-6]. Presented at the IXth International Conference on AIDS, Berlin, Germany, June 6 to 11, 1993.
8. Thomas PA, Weedon J, Krasinski K, et al. Maternal predictors of perinatal human immunodeficiency virus transmission. The New York City Perinatal HIV Transmission Collaborative Study Group. Pediatr Infect Dis J 1994;13:489-95.
9. Centers for Disease Control. Classification system for human immunodeficiency virus infection in children under 13 years of age. MMWR 1987;36:225-36.
10. Centers for Disease Control. Interpretation and use of Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infection. MMWR 1989;38:1-7.
11. Rogers MF, Ou CY, Rayfield M, et al. Use of the polymerase chain reaction for early detection of the proviral sequence of human immunodeficiency virus in infants born to seropositive mothers: New York City Collaborative Study of Maternal HIV Transmission and Montefiore Medical Center HIV Perinatal Transmission Study Group. N Engl J Med 1989;320: 1649-54.
12. Denny TN, Yogev R, Gelman R, et al. Lymphocyte subsets in healthy children during the first 5 years of life. JAMA 1992;267:1484-8.
13. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992; 41(RR-17):1-19.
14. Thea DM, Lambert G, Weedon J, et al. Benefit of primary prophylaxis prior to 18 months of age in reducing the incidence of Pneumocystis carinii pneumonia and early death in a cohort of 112 HIV-infected infants. Pediatrics 1996;97859-64.
15. The European Collaborative Study. Natural history of vertically acquired human immunodeficiency virus-1 infection. The European Collaborative Study. Pediatrics 1994;94(No. 6, Pt. 1):815-9.
16. The European Collaborative Study. Children born to women with HIV-1 infection: natural history and risk of transmission: European Collaborative Study. Lancet 1991;337:253-60.
17. Newell ML, The European Collaborative Study. The natural history of vertically acquired HIV infection. J Perinat Med 1991;Suppl. 1:257-62.
18. Tovo PA, Martino MD, Gabiano C, et al. Prognostic factors and survival in children with perinatal HIV-1 infection. Lancet 1992;339:1249-53.
19. Blanche S, Mayaux MJ, Rouzioux C, et al. Relation of the course of HIV infection in children to the severity of the disease in their mother at delivery. N Engl J Med 1994;330: 308-12.
20. The Italian Register for HIV Infection in Children. Features of children perinatally infected with HIV-1 surviving longer than 5 years. Italian Register for HIV Infection in Children. Lancet 1994;343:191-5.
21. Rogers MF, Thomas PA, Starcher ET, Noa MC, Bush TJ, Jaffe HW. Acquired immunodeficiency syndrome in children: report of the Centers for Disease Control National Surveillance, 1982 to 1985. Pediatrics 1987;79:1008-14.
22. Lampert R, Milberg J, O'Donnell R, Kristal A, Thomas P. Life table analysis of children with acquired immunodeficiency syndrome. Pediatr Infect Dis 1986;5:374-5.
23. Thomas PA, Weisfuse IB, Greenberg AE, Bernard GA, Tytun A, Stellman SD. Trends in the first ten years of AIDS in New York City: The New York City Department of Health AIDS Surveillance Team. Am J Epidemiol 1993;137:121-33.
24. Scott GB, Buck BE, Leterman JG, Bloom FL, Parks WP. Acquired immunodeficiency syndrome in infants. N Engl J Med 1984;310:76-81.
25. Turner BJ, Denison M, Eppes SC, Houchens R, Fanning T, Markson LE. Survival experience of 789 children with the acquired immunodeficiency syndrome. Pediatr Infect Dis J 1993;12:310-20.
26. Pahwa RN, Good RA, Pahwa SG. Prematurity, hypogamma-globulinemia, and neuropathology with human immunodeficiency virus (HIV) infection. Proc Natl Acad Sci USA 1987; 84:3826-30.
27. Bernstein LJ, Bye MR, Rubinstein A. Prognostic factors and life expectancy in children with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Am J Dis Child 1989;143:775-8.
28. Kline MW, Bohannon B, Kozinetz CA, Rosenblatt HM, Shearer WT. Characteristics of human immunodeficiency virus-associated mortality in pediatric patients with vertically transmitted infection. Pediatr Infect Dis J 1992;11: 676-7.
29. de Martino M, Tovo PA, Galli L, et al. Prognostic significance of immunologic changes in 675 infants perinatally exposed to human imunodeficiency virus: the Italian register for human immunodeficiency virus infection in children. J Pediatr 1991; 119:702-9.
30. Lepage P, Van de Perre P, Van Vliet G, et al. Clinical and endocrinologic manifestations in perinatally human immunodeficiency virus type 1-infected children aged 5 years or older. Am J Dis Child 1991;145:1248-51.
31. Butler KM, Husson RN, Lewis LL, Mueller BU, Venzon DJ, Pizzo PA. CD4 status and P24 antigenemia: are they useful predictors of survival in HIV-infected children receiving antiretroviral therapy? Am J Dis Child 1992;146:932-6.